HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Baodong Sun Selected Research

IGF Type 2 Receptor (Insulin-Like-Growth-Factor II Receptor)

1/2013Adjunctive β2-agonists reverse neuromuscular involvement in murine Pompe disease.
6/2011Enhanced efficacy of enzyme replacement therapy in Pompe disease through mannose-6-phosphate receptor expression in skeletal muscle.
11/2010Antibody formation and mannose-6-phosphate receptor expression impact the efficacy of muscle-specific transgene expression in murine Pompe disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Baodong Sun Research Topics

Disease

25Glycogen Storage Disease Type II (Pompe's Disease)
10/2019 - 04/2003
5Neoplasms (Cancer)
12/2021 - 02/2002
5Glycogen Storage Disease (Glycogenosis)
01/2021 - 11/2012
5Glycogen Storage Disease IIIA
09/2020 - 11/2012
4Liver Cirrhosis (Hepatic Cirrhosis)
01/2021 - 06/2014
3Fibrosis (Cirrhosis)
09/2020 - 11/2012
3Glycogen Storage Disease Type III (Cori's Disease)
09/2020 - 02/2013
3Carcinoma (Carcinomatosis)
09/2020 - 02/2002
3Glycogen Storage Disease Type IV (Andersen's Disease)
01/2017 - 01/2016
2Body Weight (Weight, Body)
01/2021 - 12/2016
2Disease Progression
01/2021 - 02/2016
2Muscle Weakness
01/2017 - 11/2005
2Liver Diseases (Liver Disease)
12/2016 - 02/2016
2Hypoglycemia (Reactive Hypoglycemia)
06/2013 - 08/2009
2Hepatorenal form of glycogen storage disease
08/2009 - 04/2008
1Glycogen Storage Disease Type Ix
01/2021
1Chronic Renal Insufficiency
01/2021
1Hyperuricemia
01/2021
1Gout
01/2021
1Inflammation (Inflammations)
01/2021
1Thymoma (Thymic Carcinoma)
09/2020
1Carcinogenesis
09/2020
1Muscular Atrophy (Muscle Atrophy)
01/2018
1Atrophy
01/2018
1Osteoarthritis
01/2017
1Muscle Hypotonia (Hypotonia)
01/2017
1Muscular Diseases (Myopathy)
06/2014
1Weight Gain
06/2013
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
03/2012
1Adenoma (Adenomas)
08/2009
1Hepatocellular Carcinoma (Hepatoma)
08/2009
1Glycogen Storage Disease Type I
08/2009
1Renal Insufficiency (Renal Failure)
08/2009
1Cardiomyopathies (Cardiomyopathy)
11/2007
1Muscular Dystrophies (Muscular Dystrophy)
12/2006
1Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
11/2005
1Respiratory Insufficiency (Respiratory Failure)
11/2005
1Colorectal Neoplasms (Colorectal Cancer)
02/2002

Drug/Important Bio-Agent (IBA)

20GlycogenIBA
01/2021 - 01/2005
19AcidsIBA
10/2019 - 04/2003
11EnzymesIBA
01/2021 - 12/2006
11alpha-Glucosidases (Acid Maltase)IBA
07/2019 - 04/2003
9GlucosidasesIBA
10/2019 - 11/2010
7human GAA protein (Myozyme)FDA Link
12/2017 - 02/2010
3Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2005
3Glycogen Debranching Enzyme System (Glycogen Debranching Enzyme)IBA
09/2020 - 11/2012
3Liver GlycogenIBA
09/2020 - 11/2012
3Proteins (Proteins, Gene)FDA Link
09/2020 - 03/2012
3Glucose-6-Phosphatase (Glucose 6 Phosphatase)IBA
10/2019 - 04/2008
3Sirolimus (Rapamycin)FDA Link
12/2017 - 06/2014
3IGF Type 2 Receptor (Insulin-Like-Growth-Factor II Receptor)IBA
01/2013 - 11/2010
2AntibodiesIBA
12/2017 - 02/2010
2polyglucosanIBA
01/2017 - 01/2016
21,4-alpha-Glucan Branching Enzyme (Glycogen Branching Enzyme)IBA
01/2017 - 01/2016
2AN 204 (AN 201)IBA
02/2002 - 02/2002
2AN 238IBA
02/2002 - 02/2002
2RC 121IBA
02/2002 - 02/2002
2Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
02/2002 - 02/2002
1LuteolinIBA
12/2021
1Anti-Allergic Agents (Antiallergic Agents)IBA
12/2021
1FlavonoidsIBA
12/2021
1C-Reactive ProteinIBA
01/2021
1CreatinineIBA
01/2021
1Eosine Yellowish-(YS) (Eosin)IBA
01/2021
1Hematoxylin (Haematoxylon)IBA
01/2021
1Interleukin-18 (Interleukin 18)IBA
01/2021
1Interleukin-6 (Interleukin 6)IBA
01/2021
1Triglycerides (Triacylglycerol)IBA
01/2021
1Uric Acid (Urate)IBA
01/2021
1DextrinsIBA
09/2020
1Complementary DNA (cDNA)IBA
09/2020
1pullulanase (limit dextrinase)IBA
09/2020
1TOR Serine-Threonine KinasesIBA
09/2020
1Diethylnitrosamine (N-Nitrosodiethylamine)IBA
09/2020
1trans-sodium crocetinate (crocetin)IBA
01/2018
1Ubiquitinated ProteinsIBA
01/2018
1Synthetic Vaccines (Recombinant Vaccines)IBA
12/2017
1CytokinesIBA
01/2017
1Creatine Kinase (Creatine Phosphokinase)IBA
02/2016
1Polysaccharides (Glycans)IBA
01/2016
1Glycogen Synthase (Synthase I)IBA
06/2014
1Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
06/2014
1Monoclonal AntibodiesIBA
01/2014
1Insulin-Like PeptidesIBA
06/2013
1Growth Hormone (Somatotropin)IBA
06/2013
1CationsIBA
01/2013
1ProteomeIBA
03/2012
1Dyneins (Dynein)IBA
08/2011
1Doxycycline (Periostat)FDA LinkGeneric
08/2011
1ClenbuterolIBA
06/2011
1mannose-6-phosphateIBA
11/2010
1Immunoglobulin G (IgG)IBA
02/2010
1Immunoglobulin E (IgE)IBA
02/2010
1Glucose (Dextrose)FDA LinkGeneric
04/2008
1Cytotoxins (Cytolysins)IBA
02/2002

Therapy/Procedure

11Enzyme Replacement Therapy
01/2018 - 11/2007
9Therapeutics
01/2021 - 02/2002
2Intravenous Injections
09/2020 - 03/2019
1Mechanical Ventilators (Ventilator)
11/2007
1Drug Therapy (Chemotherapy)
02/2002